D364-0449 Screening compound: 3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

D364-0449 Screening compound: 3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
D364-0449 Screening compound: 3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound D364-0449
3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D364-0449

Molecular Formula

C19H15ClN4O4 (C19 H15 ClN4 O4)

Compound Name

3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

IUPAC name

3-(3-chlorophenyl)-6-hydroxy-5-[5-(4-hydroxyphenyl)-45-dihydro-1H-pyrazol-3-yl]-1234-tetrahydropyrimidine-24-dione

SMILES

Oc1ccc(C(C2)NN=C2C(C(N(c2cccc(Cl)c2)C(N2)=O)=O)=C2O)cc1

InChI

InChI=1S/C19H15ClN4O4/c20-11-2-1-3-12(8-11)24-18(27)16(17(26)21-19(24)28)15-9-14(22-23-15)10-4-6-13(25)7-5-10/h1-8,14,22,25-26H,9H2,(H,21,28)/t14-/m1/s1

InChI Key

FUWJOFUFPRTSGN-CQSZACIVSA-N

MDL Number (MFCD)

MFCD27582074

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

398.81

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.020

Distribution Coefficient, logD

-3.609

Water Solubility, LogSw

-2.86

Polar Surface Area

97.977

Acid Dissociation Constant (pKa)

1.77

Base Dissociation Constant (pKb)

2.62

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

10.50

D364-0449 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Carbonic Anhydrase II Library (4939 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D364-0449 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D364-0449?
Check Price and Availability of D364-0449, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D364-0449 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D364-0449
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D364-0449
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D364-0449 available by request